Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Castle Biosciences Inc., 3 years.
Castle Biosciences Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kiniksa Pharmaceuticals International plc June 3, 202597.8%
-
Castle Biosciences Inc. May 22, 202593.0%
-
Kiniksa Pharmaceuticals International plc June 6, 202397.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −3,673 | $81.43 | $299,092 |
| Jul 29, 2026 | Kiniksa Pharmaceuticals International plc | Gift | −4,500 | — | — |
| May 29, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +2,799 | — | — |
| May 22, 2026 | Castle Biosciences Inc. | Option exercise | +13,667 | — | — |
| Mar 5, 2026 | Castle Biosciences Inc. | Option exercise | +4,748 | $3.38 | $16,048 |
| Mar 5, 2026 | Castle Biosciences Inc. | Open-market sale | −4,748 | $28.44 | $135,033 |
| Mar 5, 2026 | Castle Biosciences Inc. | Open-market sale | −2,655 | $28.51 | $75,694 |
| Jun 5, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +3,173 | — | — |
| May 21, 2025 | Castle Biosciences Inc. | Option exercise | +8,673 | — | — |
| Jun 6, 2024 | Kiniksa Pharmaceuticals International plc | Option exercise | +4,373 | — | — |
| May 25, 2024 | Castle Biosciences Inc. | Option exercise | +8,636 | — | — |
| Jun 29, 2023 | Kiniksa Pharmaceuticals International plc | Option exercise | +5,000 | — | — |
| Jun 2, 2023 | Castle Biosciences Inc. | Option exercise | +3,825 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.